Daily non-political popular news in brief.

Experimental MS drug shows promise, offers new window on disease

A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.

Read more »

Keywords: experimental, drug, shows, promise, offers, window, disease, show, offer

« Previous | Next »

Similar news on "Experimental MS drug shows promise, offers new window on disease":

1. New type of drug shows promise in attacking melanoma in an innovative way
   09-26-2007 · EurekAlert!
   An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. New research presented today at the European Cancer Conference in Barcelona found that giving the new drug in addition to chemotherapy more than doubled the amount of time patients survived without progression of their cancer.
   Similar news · Read more »
   
2. Experimental drug shows promise in advanced kidney cancer
   09-26-2007 · EurekAlert!
   A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
   Similar news · Read more »
   
3. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
4. New drug shows promise in treatment of advanced thyroid cancer
   06-04-2007 · EurekAlert!
   The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported June 3 at the annual meeting of the American Society for Clinical Oncology in Chicago.
   Similar news · Read more »
   
5. Commonly used drug offers promise for premature babies
   05-17-2007 · EurekAlert!
   Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
   Similar news · Read more »
   
6. Pilot study shows withdrawal drug offers symptom relief to Crohn's sufferers
   02-02-2007 · EurekAlert!
   A Penn State College of Medicine pilot study suggests a low dose of naltrexone, a drug used to ease symptoms of alcohol and drug addiction, may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans. The study results were released online this week in an early edition of the American Journal of Gastroenterology.
   Similar news · Read more »
   
7. Genetic breakthrough offers promise in tackling kidney tumors
   01-10-2008 · EurekAlert!
   Early tests show promising results for a new treatment for tuberous sclerosis, which can cause tumors in organs throughout the body. The UK study is led by Cardiff University's Institute of Medical Genetics, which was the first to identify the genes linked to the disease.
   Similar news · Read more »
   
8. New alzheimer's drug shows promise in clinical trial
   11-02-2006 · EurekAlert!
   The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease.
   Similar news · Read more »
   
9. Drug and procedural interventions offer better quality of life
   03-26-2007 · EurekAlert!
   Emergency and nonemergency care of cardiovascular disease have continually improved over the past decade, thanks to improved quality of care, novel procedures and better therapies. Research on improved care of cardiovascular disease shows improvements with a combination of drug and risk factor interventions. Three studies presented today at the American College of Cardiology's 56th Annual Scientific Session assess how continued improvements in cardiac care can lead to enhanced clinical practice and improved quality of life.
   Similar news · Read more »
   
10. Existing drugs show promise for treating end-stage renal disease in lupus
    11-09-2007 · EurekAlert!
    Studies in mice suggest that two drugs already approved by the US Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, MD, in presentations this week at the American College of Rheumatology in Boston.
    Similar news · Read more »